Lymphocytes,DNA adducts and genetic polymorphism for metabolic enzymes in low dose cigarette smokers

• Published in: Biomarkers 1998, Vol.3 (1), p.63-71
• Main Authors: ICHIBA, MASAYOSHI, WANG, YANPING, OISHI, HIROTAKA, ZHANG, JIUSONG, IYADOMI, MINAKO, MINAGAWA, MIHO, TOMOKUNI, KATSUMARO
• Format: Article
• Language: English
• Subjects: Biological and medical sciences; Medical sciences; Smoking Dna Adducts Lymphocyte Polymorphism; Tobacco, tobacco smoking; Toxicology
• ISSN: 1354-750X; 1366-5804
• DOI: 10.1080/135475098231372

The aim of this study was to investigate the relationship between genetic polymorphism of metabolic enzymes and DNA adduct levels in lymphocytes of low dose cigarette smokers (less than 20 cigarettes per day). We previously reported the effects of cytochrome P4501A1 (CYP1A1) and glutathione S-transferase M1 (GSTM1) on lymphocyte DNA adducts. This time we considered not only CYP1A1 and GSTM1 but also cytochrome P4502E1 (CYP2E1) and glutathione S-transferase T1 (GSTT1). DNA adducts in lymphocytes obtained from low dose cigarette smokers (n = 41) and nonsmokers (n = 56) were measured by the 32P-postlabelling method. The adduct levels were compared regarding smoking status and polymorphic genotypes of these four enzymes. The mean SD of DNA adduct levels in all low dose cigarette smokers and non-smokers was 1 05 0 83 per 108 nucleotidesand 0 85 0 35 per 108 nucleotides, respectively. In low dose cigarette smokers, adduct levels were higher in the rare homozygous (MM) for CYP1A1-exon 7 polymorphism compared with the other types such as common homozygous (WW) and heterozygous (WM). CYP1A1-WM, MM in combination with GSTM1 null showed highest adduct levelamong low smokers. The low smokers with rare homozygous for CYP2E1 Dra1 polymorphism tended to have lower adduct levels than wild types. Low dose cigarette smokers with combined GSTM1 null and T1 null had a higher tendency for adduct levels than others. However none of the differences reached statistical significance.